Splenic marginal-zone lymphoma: One or more entities? A histologic, immunohistochemical, and molecular study of 42 cases

American Journal of Surgical Pathology

Volumn 31, Issue 3, 2007, Pages 438-446

  Papadaki, Theodora ^a   Stamatopoulos, Kostas ^b,d   Belessi, Chrysoula ^c   Pouliou, Evi ^a   Parasi, Aikaterini ^c   Douka, Vassiliki ^b   Laoutaris, Nikolaos ^c   Fassas, Athanasios ^b   Anagnostopoulos, Achilles ^b   Anagnostou, Dimitra ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

^c GENERAL HOSPITAL OF NIKEA   (Greece)

^d NONE   (Greece)

Author keywords

Histology; IG genes; Immunohistochemistry; Splenic marginal zone lymphoma

Indexed keywords

CD27 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN D; DNA; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; RNA; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; LYMPHOCYTE SUBPOPULATION; SPLEEN MARGINAL ZONE LYMPHOMA; SPLENECTOMY; STRUCTURAL HOMOLOGY; TISSUE SECTION; GENE REARRANGEMENT; GENETICS; IMMUNOPHENOTYPING; LYMPHOMA; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SPLEEN; SPLEEN TUMOR;

DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENE REARRANGEMENT, B-LYMPHOCYTE, LIGHT CHAIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOPHENOTYPING; LYMPHOMA; RNA, NEOPLASM; SPLEEN; SPLENECTOMY; SPLENIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34247596120     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000213419.08009.b0     Document Type: Article

References (53)

1. Adami F, Chilosi M, Lestani M, et al. A CD5+ leukemic lymphoma with monocytoid features: an unusual B-cell lymphoma mimicking hairy-cell leukemia. Acta Haematol. 1993;89:94-99.
2. Algara P, Mateo MS, Sanchez-Beato M, et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and diverse clinical course. Blood. 2002;99:1299-1304.
3. Arcaini L, Paulli M, Boveri E, et al. Marginal zone-related neoplasms of splenic and nodal origin. Haematologica. 2003;88:80-93.
4. Bahler DW, Pindzola JA, Swerdlow SH. Splenic marginal zone lymphomas appear to originate from different B cell types. Am J Pathol. 2002;161:81-88.
5. Cariappa A, Tang M, Parng C, et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity. 2001;14:603-615.
6. Dogan A, Isaacson PG. Splenic marginal zone lymphoma. Semin Diagn Pathol. 2003;20:121-127.
7. Dono M, Ferrarini M. Immunoglobulin gene mutation patterns and heterogeneity of marginal zone lymphoma. Methods Mol Med. 2005;115:173-196.
8. Dono M, Zupo S, Leanza N, et al. Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J Immunol. 2000;164:5596-5604.
9. Dono M, Zupo S, Colombo M, et al. The human marginal zone B cell. Ann N Y Acad Sci. 2003;987:117-124.
10. Dunn-Walters DK, Isaacson PG, Spencer J. Analysis of mutations in immunoglobulin heavy chain variable region genes of micro-dissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med. 1995;182:559-566.
11. Dunn-Walters DK, Boursier L, Spencer J, et al. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation. Hum Pathol. 1998;29:585-593.
12. Franco V, Florena AM, Iannitto E. Splenic marginal zone lymphoma. Blood. 2003;101:2464-2472.
13. Giudicelli V, Chaume D, Lefranc M-P. IMGT/V-QUEST, an integrated software for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucl Acids Res. 2004;32:W435-W440.
14. Hammer RD, Glick AD, Greer JP, et al. Splenic marginal zone lymphoma. A distinct B-cell neoplasm. Am J Surg Pathol. 1996;20:613-626.
15. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
16. Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347:89-94.
17. Isaacson PG. Splenic marginal zone lymphoma. Blood. 1996;88:751-752.
18. Isaacson PG, Matutes E, Burke M, et al. The histopathology of splenic lymphoma with villous lymphocytes. Blood. 1994;84:3828-3834.
19. Kenny JJ, Rezanka LJ, Lustig A, et al. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. J Immunol. 2000;164:4111-4119.
20. Kouskoff V, Lacaud G, Nemazee D. T cell-independent rescue of B lymphocytes from peripheral immune tolerance. Science. 2000;287:2501-2503.
21. Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med. 2003;197:939-945.
22. Lefranc M-P. IMGTs databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis, http://imgt.cines.fr. Leukemia. 2003;17:260-266.
23. Lefranc M-P, Giudicelli V, Kaas Q, et al. IMGT, the international ImMunoGeneTics information systems®. Nucleic Acids Res. 2005;33:D593-D597.
24. MacLennan IC, Toellner KM, Cunningham AF, et al. Extrafollicular antibody responses. Immunol Rev. 2003;194:8-18.
25. Maes B, De Wolf-Peeters C. Marginal zone cell lymphoma-an update on recent advances. Histopathology. 2002;40:117-126.
26. Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol. 2002;2:323-335.
27. Mateo MS, Mollejo M, Villuendas R, et al. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 50 non-coding region of the bcl-6 gene. Leukemia. 2001;15:628-634.
28. McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol. 2005;23:487-513.
29. Messmer BT, Albesiano E, Efremov DG, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med. 2004;200:519-525.
30. Mollejo M, Menarguez J, Lloret E, et al. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases. Am J Surg Pathol. 1995;19:1146-1157.
31. Monson NL, Foster SJ, Brezinschek HP, et al. The role of CD40-CD40 ligand (CD154) interactions in immunoglobulin light chain repertoire generation and somatic mutation. Clin Immunol. 2001;100:71-81.
32. Pillai S, Cariappa A, Moran ST. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol Rev. 2004;97:206-218.
33. Pillai S, Cariappa A, Moran ST. Marginal zone B cells. Annu Rev Immunol. 2005;23:161-196.
34. Pittaluga S, Verhoef G, Criel A, et al. "Small" B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis. Am J Surg Pathol. 1996;20:211-223.
35. Potter KN, Hobby P, Klijn S, et al. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol. 2002;169:3777-3782.
36. Rosso R, Neiman RS, Paulli M, et al. Splenic marginal zone cell lymphoma: report of an indolent variant without massive splenomegaly presumably representing an early phase of the disease. Hum Pathol. 1995;26:39-46.
37. Schmid C, Kirkham N, Diss T, et al. Splenic marginal zone cell lymphoma. Am J Surg Pathol. 1992;16:455-466.
38. Silberstein LE, George A, Durdik JM, et al. The V4-34 encoded anti-i autoantibodies recognize a large subset of human and mouse B-cells. Blood Cells Mol Dis. 1996;22:126-138.
39. Sole F, Salido M, Espinet B, et al. Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Haematologica. 2001;86:71-77.
40. Stamatopoulos K, Belessi C, Papadaki T, et al. Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma. Mol Med. 2004;10:89-95.
41. Stamatopoulos K, Belessi C, Hadzidimitriou A, et al. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood. 2005;106:3575-3583.
42. Tierens A, Delabie J, Michiels L, et al. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood. 1999;93:226-234.
43. Tierens A, Delabie J, Malecka A, et al. Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations. Am J Pathol. 2003;162:681-689.
44. Toellner KM, Jenkinson WE, Taylor DR, et al. Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J Exp Med. 2002;195:383-389.
45. Van Huyen JP, Molina T, Delmer A, et al. Splenic marginal zone lymphoma with or without plasmacytic differentiation. Am J Surg Pathol. 2000;24:1581-1592.
46. Weller S, Faili A, Garcia C, et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci USA. 2001;98:1166-1170.
47. Weller S, Braun MC, Tan BK, et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood. 2004;104:3647-3654.
48. Widhopf GF II, Kipps TJ. Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells. J Immunol. 2001;166:95-102.
49. Widhopf GF II, Rassenti LZ, Toy TL, et al. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood. 2004;104:2499-2504.
50. Wu CD, Jackson CL, Medeiros LJ. Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases. Am J Clin Pathol. 1996;105:277-285.
51. Zandvoort A, Timens W. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin Exp Immunol. 2002;130:4-11.
52. Zhu D, Oscier DG, Stevenson FK. Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes. Blood. 1995;85:1603-1607.
53. Zhu D, Orchard J, Oscier DG, et al. V(H)gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo. Blood. 2002;100:2659-2661.